Cancer Information Highlights, October 31, 2018

National Cancer Institute sent this bulletin at 10/31/2018 01:40 PM EDT
National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share
Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
Studying “Total Diet” and Its Impact on Health, Including Cancer Risk
healthy food and unhealthy food   Researchers have begun taking a more holistic approach to nutrition research, looking at dietary patterns across the lifespan versus individual foods or nutrients. Learn how research on the connection between diet and disease is evolving.
Immunotherapy Drug Approved for Advanced Squamous Cell Skin Cancer
Squamous cell carcinoma cells   The Food and Drug Administration (FDA) approved the immunotherapy drug cemiplimab (Libtayo) for an advanced form of cutaneous squamous cell carcinoma (SCC), a common type of skin cancer. It is the first agent to be approved specifically for advanced SCC.
CAR T-Cell Therapy Infographic

This illustration shows the steps for creating CAR T-cell therapy, a type of treatment in which a patient's T cells are changed in the laboratory so they will attack cancer cells. T cells are part of the immune system.
Cancer in Children and Adolescents

This recently updated page covers statistics, types, causes, and treatment of childhood cancers in the United States.
PDQ Summary Updates
Childhood Craniopharyngioma Treatment

We’ve updated our childhood craniopharyngioma summary to include intracavitary interferon-alfa as a standard treatment for this disease.
Drug Information Updates
Dacomitinib for Non-Small Cell Lung Cancer

We’ve added a new drug information summary for dacomitinib (Vizimpro). It was recently approved by FDA as first-line treatment for non-small cell lung cancer in patients whose tumors have certain mutations in the EGFR gene.
New Drug for Leukemia and Lymphomas

We’ve added a new drug information summary for duvelisib (Copiktra). It was recently approved by FDA to treat chronic lymphocytic leukemia, small lymphocytic lymphoma, or follicular lymphoma that came back or did not respond to treatment after at least two other therapies. 
 
Also of Interest
Talking to Children about Your Cancer

Even though your children may be upset when they learn about your cancer, it is important not to pretend that everything is okay. This page helps you understand what your children need to know about your cancer and gives ideas on how to talk with them.
Smokefree.gov and the Great American Smokeout

Get ready for the Great American Smokeout, coming on Thursday, November 15. On Smokefree.gov you’ll find support, tips, tools, and expert advice to help you or someone you love quit smoking.
Lung Cancer Prevention

November is Lung Cancer Awareness Month. Learn about factors that can increase your risk of lung cancer and those that can protect you from lung cancer.